Physician profile
Brian Steinmetz
NPI 1285831651
$3,288.04
in general payments reported to CMS, 2019-2025
12 companies · $586 in 2025
The $586 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $76.79 · 2021: $37.57 · 2022: $281 · 2023: $390 · 2024: $621 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,416.60 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $847.89 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16, Patient Trial Kit |
| Biotronik Nro, INC. | $202.27 | 2024 | Prospera |
| Spr Therapeutics, INC | $188.73 | 2024-2025 | Sprint Pns System |
| Vertiflex, INC. | $171.81 | 2019 | |
| Medtronic, INC. | $138.93 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Vertos Medical, INC. | $119.69 | 2022 | |
| Abbott Laboratories | $109.93 | 2019-2020 | |
| Terumo Bct, INC. | $28.82 | 2019 | |
| Stryker Corporation | $25.80 | 2019 | |
| Si-Bone, INC. | $23.21 | 2021 | |
| Abbvie INC. | $14.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Steinmetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.